OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA
BETHLEHEM, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home...
COVID-19
Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome
Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome DUBLIN, Ireland,...
BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners
Enhanced products For Use by Holistic Healthcare Practitioners – $21b US Market For Alternative Medicine Goods and Services LAS VEGAS,...
Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis
Dupixent®(dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis First and...
First Patient Enrolled in the Streamlined Localization (STREAMLoc) Registry Study Using SCOUT® at Biopsy in Canada
Prospective, observational study to assess the clinical utility of the SCOUT® Radar Localization System (SCOUT) in real-world practiceSOUTH JORDAN, Utah,...
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
• Phase 1 dose-escalation study started at clinical sites in the U.S. • Milestone demonstrates CureVac’s and GSK’s continued execution...
CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
Rolling submission to accelerate time to marketing authorization of CVnCoV in SwitzerlandReview process started with submission of first CVnCoV data...
CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant (South African Variant) in Preclinical Challenge Study
First challenge infection study in preclinical mouse model to provide evidence for protection against SARS-CoV-2 variantCVnCoV induces robust antibody titers...
How Medical Technology is Aiding the Global Fight Against Covid-19
Healthcare organizations worldwide have been forced to adapt and evolve as the coronavirus pandemic has raged across the world. Existing...
Humanity Supersedes Technology with Covid Vaccines
Lessons from the most important tech adoption of our century: the COVID-19 vaccine By Cameron Turner, VP Data Science and...
Innovative Product ExoFlo™ Fulfills Unmet but Urgent Medical Need in COVID-19 Treatment
Medical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) Treatment...
CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Demonstrated Efficient Protection of Non-Human Primates During SARS-CoV-2 Challenge Infection
Data provided further evidence on immunogenicity and protective efficacy of CVnCoV ∙ Induction of robust antibody and T cell responses...
Guru Nanda Donates 6.5 Million Masks to Various Charities and Social Concerns Across the Country
Guru Nanda, a Buena Park-based manufacturer of premium farm-to-home aromatherapy and other health and wellness products, has donated more than...
Hotel Paso del Norte Among First Hotels To Open With Virus-killing Air Filtration System Throughout Property
Highly coveted amenities at this luxury hotel include optimal air quality (El Paso, TX) August 19, 2020 – In El...
ACT Lighting Announces Full Range of UV-C Disinfecting Products From Luxibel and Golden Sea
Challenging times call for innovative technology solutions. The COVID-19 pandemic has increased the demand for UV-C lighting products offering reliable disinfection,...
With The Rise Of Surveillance, People’s Digital Rights Suffer
NordVPN expert shares his views on COVID-19 related digital monitoring By Daniel Markuson, digital privacy expert at NordVPN Governments around...
Lab And Healthcare Flooring Requirements For Covid-19
DATELINE: AVON, M The response to the COVID-19 crisis has led to a number of temporary facilities to take the...
Pharnext and the University Hospital Institute Méditerranée Infection Announce a Joint Effort to Evaluate Repurposed Drugs for Potential Use Against the COVID-19 Virus
Rapid in vitro testing of repurposed drug candidates identified by Pharnext's PLEOTHERAPYTM Artificial Intelligence platformPARIS, France, 8:00am, April 22, 2020 (CET) - Pharnext SA...
Digital Front Doors: The Future of Healthcare is Now
By Rajesh Midha, Chief Strategy & Operating Officer and Healthcare Practice Lead at Bottle Rocket The idea of a digital...
New Nasal Spray Studied as a Possible COVID-19 Solution
SALT LAKE CITY, APRIL 20, 2020 – In what could be an absolute game-changer in the global quest to treat...